Breaks Categories: News

SaturdayMar 16, 2024 8:30 am

NetworkNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Closes on $3.5M Private Placement

Gaxos.ai (NASDAQ: GXAI), a company developing artificial intelligence applications across various sectors, announced that it has closed its previously announced private placement. The private placement comprised the purchase and sale of an aggregate of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a price of $5.57 per unit (or per pre-funded warrant in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series…

Continue Reading

FridayMar 15, 2024 4:12 pm

NetworkNewsBreaks – Diamond Lake Minerals Inc.’s (DLMI) Leadership in Tokenization of Real Estate Assets Spotlighted in Recent Article

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, was featured in a recent Benzinga article. The piece discussed the tokenization of real estate assets and DLMI’s role as one of the companies leading this quiet revolution. According to the article, tokenization, which refers to the process of converting physical assets like real estate or precious metals into digital tokens that can be traded on a blockchain network, allows for easier and more efficient transfer of ownership and increased liquidity. The article stated, “DLMI has spent a substantial…

Continue Reading

FridayMar 15, 2024 1:01 pm

NetworkNewsBreaks – Upstream Empowering Issuers with Access to Global Investor Base, Suite of Innovative Tools

Upstream, a MERJ Exchange market and trading app, has published a blog article discussing how it empowers companies to engage with their shareholders and enhance investor relations (“IR”) through dual listing. The article, by Anastasia Samaras, notes that Upstream puts marketing at the forefront of dual listings, offering issuers a media package with ~$100k of IR value, featuring interviews, PRs, videos, and other collateral to amplify visibility and introduce companies to a global investor base who can access their shares on Upstream. “Upstream goes beyond traditional IR by providing smart-contract-powered shareholder engagement tools. Issuers are taking advantage of Upstream’s web3…

Continue Reading

FridayMar 15, 2024 12:14 pm

NetworkNewsBreaks – The Cannabis Place Opens Its New York City Flagship State-Licensed Dispensary in Middle Village Area

The Cannabis Place, a licensed adult-use dispensary operator in New York and New Jersey, is reporting the grand opening of its New York City flagship licensed dispensary. The location at 74-03 Metropolitan Avenue, Middle Village in Queens, will open its doors on Saturday, March 16, at 4.20 p.m. ET. “We picked this weekend to open because it’s symbolic in many ways. By opening our state-licensed dispensary in the Middle Village area of New York City, we are providing New Yorkers with access to licensed and regulated New York Cannabis products,” said Osbert Orduña, The Cannabis Place founder and CEO. “We…

Continue Reading

FridayMar 15, 2024 11:41 am

NetworkNewsBreaks – Tether Curates Series of Events for Its Third Annual Budtender Appreciation Week

Tether, a leading name in the Canadian cannabis industry, has curated a week-long series of opportunities, including retail visits and educational sampling events, as part of the upcoming third annual Budtender Appreciation Week. “B-Week,” an initiative created to recognize and celebrate the contributions of cannabis retail workers across Canada, is set for March 24 through March 31, 2024, promising to be bigger than ever, featuring sampling events in Vancouver, British Columbia, Oakville, Ontario, and Edmonton, Alberta. “Green Hedge and our portfolio of brands are proud to be part of Tether’s Budtender Appreciation Week at events across Canada,” said Steve Crichton,…

Continue Reading

FridayMar 15, 2024 11:37 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced the publication of peer-reviewed research, titled “Protein Corona Composition of Gold Nanocrystals.” The publication appeared in the journal ACS Pharmacology & Translational Science and fully characterized the proteins from human blood plasma that form the protein corona of the gold nanocrystals of CNM-Au8(R), Clene’s investigational drug in development for the treatment of neurodegenerative diseases. “The protein corona of CNM-Au8 gold nanocrystals, tailored for brain delivery…

Continue Reading

FridayMar 15, 2024 10:30 am

NetworkNewsBreaks – Cognition Therapeutics Inc. (NASDAQ: CGTX) Closes on $11.5M Public Offering

Cognition Therapeutics (NASDAQ: CGTX), a clinical-stage company developing product candidates designed to treat neurodegenerative disorders, has closed on its previously announced underwritten public offering. The offering was comprised of 6,571,428 shares of its common stock. According to the announcement, each share of common stock was sold at $1.75 per share, resulting in approximately $11.5 million in gross proceeds before deductions, commissions and expenses. Cognition Therapeutics anticipates using the funds from the offering for research, clinical development, process development and manufacturing, working capital, capital expenditures and other general corporate purposes. Titan Partners Group, a division of American Capital Partners, acted as…

Continue Reading

ThursdayMar 14, 2024 3:21 pm

NetworkNewsBreaks – BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: BXT) Announces Highly Promising Results from ODF Cladribine PK Study

BioNxt (CSE: BNXT) (OTCQB: BNXTF) (FSE: BXT) has announced completion of the comparative pharmacokinetic (“PK”) study for its oral dissolvable film (“ODF”) based proprietary Cladribine product for the treatment of multiple sclerosis (“MS”). The company reported that the animal PK study results are highly promising and demonstrated comparable rapid absorption and systemic exposure between BioNxt’s ODF product and the name-brand reference drug in all samples. “These results are a significant milestone for BioNxt. We have demonstrated that our ODF platform is an effective drug delivery system for cytostatic drugs via transmucosal absorption,” said BioNxt CEO Hugh Rogers. “With our recently…

Continue Reading

ThursdayMar 14, 2024 3:11 pm

NetworkNewsBreaks – Roth Capital Partners Continues Collaboration with IBN as Corporate Communications Partner for 36th Annual Conference

Roth Capital Partners (Roth MKM), a relationship-driven investment bank dedicated to serving growth companies and their investors, has selected IBN as a media sponsor for next week’s 36th Annual Roth Conference. The partnership is a continued collaboration as IBN, an innovative corporate communications firm and content distributor, has provided corporate communications and coverage for Roth events previously. The 36th Annual Roth Conference is scheduled for March 17–19, 2024, in Laguna Niguel, California. The ROTH event creates an ideal opportunity for executives from an estimated 500 selected companies to engage with potential investors during meaningful one-on-one and small-group discussions; the conference…

Continue Reading

ThursdayMar 14, 2024 3:04 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as senior vice president of finance and operations at Rain Oncology Inc., a late-stage precision oncology biotech company. In that position, he was pivotal in building and leading the company’s financial organization, resulting in significant growth…

Continue Reading